Today: 27 June 2026
Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk
10 February 2026
1 min read

Chevron stock slips as Tengiz field ramps back up, oil traders eye Iran risk

New York, Feb 10, 2026, 12:00 EST — Regular session

  • Chevron shares slipped in midday trading, with crude prices hovering around their latest marks.
  • Chevron’s Kazakhstan oilfield, hit by fires in January, is now ramping back up toward full production.
  • U.S. oil inventory data is on traders’ radar, along with anything suggesting new supply disruptions.

Chevron shares slipped Tuesday, trimming a bit of Monday’s rally. Reuters reported that output at the Tengiz oilfield in Kazakhstan—where Chevron leads operations—had bounced back to roughly 60% of peak levels after being hit by an outage in January.

The update carries weight—Tengiz remains a key wellspring for global crude, and its hiccup jolted Kazakhstan’s flow abroad. A quicker restart? That could take some air out of the supply worries propping up oil-linked stocks this month.

Oil barely budged, leaving U.S. energy stocks tethered to news flow instead of any real movement. “The market is still focused on the tensions between Iran and the U.S.,” said Tamas Varga, oil analyst at PVM. IG’s Tony Sycamore noted a “modest risk premium” holding in place as traders eyed the possibility of escalation and supply snags. Reuters

Chevron slipped 0.3% to $182.08 as of midday. Shares bounced between $180.88 and $183.22 earlier Tuesday, market data showed.

On Feb. 8, Tengiz turned out roughly 550,000 barrels per day, according to two industry sources with knowledge of the numbers. Bpd—barrels per day—serves as oil’s standard yardstick.

According to the sources, the field is targeting a ramp-up to roughly 950,000 bpd by Feb. 23. Tengiz represents close to 40% of all Kazakhstan oil production, Reuters noted.

Kazakhstan’s oil and condensate output rebounded to roughly 1.6 million bpd in early February, up from January’s 1.27 million bpd average, according to the report. Still, the previous production slump kept a lid on exports through the Caspian Pipeline Consortium.

BP dropped in European trading, with the oil giant pausing buybacks and channeling more cash to pay down debt—a move that highlights how oil majors aren’t moving in lockstep on shareholder returns as crude prices lose heat from last year’s peak.

But the risks for Chevron are clear enough. Should Tengiz remain slow to ramp back up, or crude prices soften as geopolitical tensions ease, the stock could see its energy-driven backing slip away.

Investors now have their eyes on a stack of short-term data: the American Petroleum Institute’s weekly U.S. oil inventories due out later Tuesday, followed by the U.S. Energy Information Administration numbers on Wednesday. Also up for grabs—a progress check on Tengiz and whether it’s on track to hit full output before the Feb. 23 target.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Strategy Stock Drops Nearly 25% Amid Crypto Market Turmoil
    June 27, 2026, 10:34 AM EDT. Strategy (MSTR) shares plunged 24.80% last week, triggering fresh concern across cryptocurrency investors. The fall added pressure on the market amid broader crypto volatility. Experts attribute the slide to amplified fears regarding bitcoin and other digital assets, with investors pulling back. Strategy, heavily linked to crypto through its bitcoin holdings, remains a bellwether for the sector. The drop underscores ongoing instability in digital asset markets and heightened sensitivity to regulatory and market shifts.

Latest articles

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

27 June 2026
ImmunityBio surged 11.8% to $8.71 on Friday with volume tripling its average, as Russell index reconstitution took effect; Monday’s trading will reveal if demand persists or if the spike was driven by index flows, with no imminent company events and recent insider selling accounting for just 0.06% of Friday’s volume.
Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

Lucid (NASDAQ:LCID) jumps, adding about $312 million after $158 million cost plan

27 June 2026
Lucid surged 15.6% Friday, adding $312 million in equity value—almost double the $158 million in annualized savings from this week’s restructuring plan that cut 18% of its U.S. workforce. Friday’s volume equaled 54% of reported short interest, but the rally outpaced cost-cutting fundamentals, leaving less room for further gains based solely on headcount cuts.
Court ruling on student loans hits private lenders’ health grad loan push

Court ruling on student loans hits private lenders’ health grad loan push

27 June 2026
Judge blocks narrow “professional degree” rule, letting more health-care grad students keep higher federal loan caps; $7.87B in 2023-24 borrowing above new limits remains in federal market, trimming but not eliminating the $4.5B-$5B annual private loan growth Sallie Mae projected from Grad PLUS loan cuts.
Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

Moderna (NASDAQ:MRNA) price targets draw attention as shares rally into short holiday week

27 June 2026
Moderna soared 12.6% Friday on heavy volume after unveiling new in vivo CAR-T pipeline plans, closing at $67.27—52% above the mean analyst target but still 14.5% below Piper Sandler’s new $77 target. The rally followed Science Day updates, even as analysts note the main new asset is preclinical and cash burn continues, with $7.5B cash at March-end and a projected $3B R&D spend for 2026.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop